Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03340532 · ClinicalTrials.gov registry record · NA

HealthSmart: Promoting Healthy Lifestyles for Young Adult Cancer Survivors Using Educational Videos

A NA study of Environmental Exposure to Ultraviolet Light, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
266
Enrollment target
1
Study location

NCT03340532: Completed NA study of Environmental Exposure to Ultraviolet Light, sponsored by Dana-Farber Cancer Institute.

NCT03340532 is a NA study of Environmental Exposure to Ultraviolet Light that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 266 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03340532, a NA study of Environmental Exposure to Ultraviolet Light, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
266 participants
Enrollment target
1
Study location

Study Summary

To assess the efficacy of the two SunSmart intervention videos to change sun protection attitudes and behaviors

Primary Outcome

SP index is comprised of 15 self-report items assessing SP Behaviors

Interventions

  • OTHER THE INFORMATION + APPEARANCE VIDEO
  • OTHER Information SunSmart video
  • OTHER Sleep hygiene video

Study Locations (1)

Massachusetts

  • Dana Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 266 participants
Start Date 2018-01-30
Est. Completion 2021-09-27
Phase NA
Dana-Farber Cancer Institute

781 total trials

What the finished NCT03340532 record still lists

NCT03340532 is an interventional study that assigns participants to a tested intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).

The record links to 1 condition, with Environmental Exposure to Ultraviolet Light appearing as the primary indexed condition, and to 3 interventions - of which THE INFORMATION + APPEARANCE VIDEO is the first listed.

NCT03340532 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03340532 about?

NCT03340532 is a clinical study titled "HealthSmart: Promoting Healthy Lifestyles for Young Adult Cancer Survivors Using Educational Videos". To assess the efficacy of the two SunSmart intervention videos to change sun protection attitudes and behaviors

What is the current status of trial NCT03340532?

This trial is currently completed. It is a NA study. The enrollment target is 266 participants. The study started on 2018-01-30. Estimated completion is 2021-09-27.

What conditions does trial NCT03340532 study?

This clinical trial studies the following conditions: Environmental Exposure to Ultraviolet Light.

What interventions are being tested in trial NCT03340532?

The interventions under investigation include: THE INFORMATION + APPEARANCE VIDEO (OTHER), Information SunSmart video (OTHER), Sleep hygiene video (OTHER).

Who is sponsoring clinical trial NCT03340532?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03340532 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT03340532's enrollment target sits among peer trials

266 395th of 2000 higher than 1,606 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05098652 · 266 participants · NA

    Coaching Dementia Caregivers to Master Care-Resistant Behavior

  • NCT06088277 · 266 participants · NA

    Texting to Reduce Human Immunodeficiency Virus (HIV) Risk

  • NCT06261814 · 266 participants · Phase 2

    Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

  • NCT06312124 · 266 participants · NA

    A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03340532, the US trial registry maintained by the National Library of Medicine. NCT03340532 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.